In millions, except per share items | Mar-31-14 | Dec-31-13 | Sep-30-13 | Jun-30-13 | Mar-31-13 | Dec-31-12 | Sep-30-12 | Jun-30-12 |
| 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
Cash flows from operating activities: | | | | | | | | |
Net earnings | 1.4 | 0.9 | 0.5 | | 1.0 | 0.6 | 0.3 | |
Adjustments to reconcile net earnings to net cash from (used for) operating activities: | | | | | | | | |
Allocated ESOP shares | 0.1 | 0.1 | 0.1 | | 0.1 | 0.1 | 0.0 | |
Depreciation and amortization expense | 1.4 | 0.9 | 0.5 | | 1.4 | 0.9 | 0.5 | |
Amortization of premiums (discounts), net on investment securities | 0.5 | 0.4 | 0.2 | | 0.5 | 0.3 | 0.1 | |
Provision for loan losses | | | | | 0.8 | 0.6 | 0.3 | |
Amortization of deferred loan fees, net | -0.1 | -0.1 | 0.0 | | -0.1 | -0.1 | -0.1 | |
(Gain) loss on sale of investment securities | 0.0 | 0.0 | | | 0.0 | 0.0 | 0.0 | |
(Gain) loss on sale of foreclosed real estate, net | 0.1 | 0.1 | 0.0 | | 0.2 | 0.2 | 0.2 | |
(Gain) loss on sale of fixed assets, net | | | | | 0.0 | 0.0 | 0.0 | |
Deferred tax expense (benefit) | 0.6 | 0.4 | 0.2 | | 0.3 | 0.2 | 0.1 | |
Stock options expensed | 0.0 | 0.0 | 0.0 | | 0.0 | 0.0 | 0.0 | |
Originations of mortgage loans held for sale | -4.2 | -3.3 | -1.6 | | -15.0 | -12.4 | -6.4 | |
Proceeds from sale of mortgage loans | 4.2 | 3.0 | 1.6 | | 14.9 | 11.4 | 6.0 | |
Increase in cash value of life insurance | -0.2 | -0.1 | -0.1 | | -0.2 | -0.1 | -0.1 | |
Decrease (increase) in: | | | | | | | | |
Accrued interest receivable | 0.1 | 0.1 | 0.1 | | 0.1 | 0.2 | 0.1 | |
Other assets | 3.7 | 3.5 | 1.3 | | 0.2 | 0.8 | 0.5 | |
Increase (decrease) in other liabilities and accrued income taxes | -4.3 | -3.7 | -1.3 | | 0.6 | 0.7 | 0.2 | |
Net cash provided by (used for) operating activities | 3.2 | 2.2 | 1.5 | | 4.7 | 3.4 | 1.7 | |
|
Cash flows used for investing activities: | | | | | | | | |
Loan originations, net of principal collections | -22.3 | -10.1 | 6.5 | | 7.9 | 3.4 | 7.3 | |
Investment securities classified as available-for-sale: | | | | | | | | |
Proceeds from maturities, calls and prepayments | 18.3 | 12.2 | 5.3 | | 23.4 | 16.4 | 11.5 | |
Proceeds from sale | | | | | 0.1 | 0.1 | | |
Purchase of securities | -10.9 | -10.9 | -10.9 | | -39.9 | -29.1 | -13.8 | |
Proceeds from sale of premises and equipment | | | | | | | | |
Purchase of premises and equipment | -0.2 | -0.2 | -0.1 | | -0.3 | -0.2 | 0.0 | |
Proceeds from sale of (additions to) foreclosed real estate, net | 1.4 | 0.9 | 0.3 | | 1.4 | 1.1 | 0.9 | |
Net cash provided by (used for) investing activities | -13.7 | -8.1 | 1.1 | | -7.3 | -8.4 | 5.7 | |
|
Cash flows from financing activities: | | | | | | | | |
Net decrease in deposits | -15.7 | -11.6 | -3.7 | | -18.5 | -4.7 | -16.5 | |
Net increase (decrease) in repurchase agreements | 0.0 | 0.3 | 0.4 | | 0.2 | 0.4 | 0.3 | |
Repayment of FHLB advances | 56.0 | 0.0 | -0.2 | | -0.2 | -0.2 | -0.2 | |
Proceeds from FHLB advances | -33.5 | 9.5 | | | | | | |
Purchase of treasury stock | 0.0 | 0.0 | 0.0 | | -0.1 | 0.0 | 0.0 | |
Net cash provided by (used for) financing activities | 6.8 | -1.9 | -3.5 | | -18.6 | -4.4 | -16.4 | |
Net increase (decrease) in cash, cash equivalents and interest-earning deposits | -3.6 | -7.8 | -0.9 | | -21.2 | -9.4 | -9.0 | |
|
Cash, cash equivalents and interest-earning deposits at beginning of period | | | | | | | | |
Cash, cash equivalents and interest-earning deposits at end of period | | | | | | | | |
Supplemental disclosures of cash flow information: | | | | | | | | |
Cash paid during period for: | | | | | | | | |
Interest on deposits | | | | | | | | |
Interest on borrowed funds | | | | | | | | |
Interest on subordinated debentures | | | | | | | | |
Income taxes | | | | | 0.0 | | | |
Real estate acquired in settlement of loans | 1.3 | 1.2 | 0.8 | | 3.7 | 3.3 | 2.1 | |